Combination Therapy Device Hastens Wound Healing

The portable system can be used together with any treatment modality.

The BRH-A2 system includes proprietary integrated user-friendly software that provides detailed patient data, including specific data regarding the location, type, and characteristics of specific wounds, which can be saved for improved patient management. Using algorithms, the device can accurately measure ulcer size, even while the edges may not be clearly defined due to loss of tissue. The system, which has been approved by the U.S. Food and Drug Administration (FDA), also stores individual clinical data on thousands of patients for efficient treatment and follow-up procedures.

“The market for products that ease the pain of chronic wounds is large and growing. Our vision is to become the gold standard for treatment of chronic wounds of all kinds, including pressure wounds, diabetic leg wounds, and wounds caused as a result of ischemia,” said Motti Oderberg, CEO of BRH Medical. “We are now exploring the most efficient way to penetrate the market, and are currently focusing on identifying strategic partnerships.”

Electrostimulation is known to pull taut fibroblasts and resultant collagen, yielding a stronger weave; in addition, a proven effect of ultrasound is stimulating fibroblasts to create collagen, and also inducing the new collagen to lay out in a more ordered pattern, resulting in a better weave for epithelialization. The end result of combining the two technologies is a more ordered and tighter collagen weave.

Related Links:
BRH Medical